{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T04:58:29Z","timestamp":1792213109590,"version":"4.4.0"},"reference-count":100,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1093\/brain\/awh132","type":"journal-article","created":{"date-parts":[[2004,5,11]],"date-time":"2004-05-11T00:23:33Z","timestamp":1084235013000},"page":"1237-1251","source":"Crossref","is-referenced-by-count":153,"title":["Cortical selective vulnerability in motor neuron disease: a morphometric study"],"prefix":"10.1093","volume":"127","author":[{"given":"S.","family":"Maekawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Al\u2010Sarraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kibble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Landau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Parnavelas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Cotter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Everall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. N.","family":"Leigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2004,6]]},"reference":[{"key":"key\n\t\t\t\t20170624054850_AWH132C1","doi-asserted-by":"crossref","unstructured":"Abercrombie M. Estimation of nuclear population from microtomic sections. Anat Rev1946; 94: 239.","DOI":"10.1002\/ar.1090940210"},{"key":"key\n\t\t\t\t20170624054850_AWH132C2","doi-asserted-by":"crossref","unstructured":"Abrahams S, Leigh PN, Kew JJ, Goldstein LH, Lloyd CM, Brooks DJ. A positron emission tomography study of frontal lobe function (verbal fluency) in amyotrophic lateral sclerosis. J Neurol Sci1995; 129 Suppl: 44\u20136.","DOI":"10.1016\/0022-510X(95)00060-F"},{"key":"key\n\t\t\t\t20170624054850_AWH132C3","doi-asserted-by":"crossref","unstructured":"Abrahams S, Goldstein LH, Kew JJ, Brooks DJ, Lloyd CM, Frith CD, et al. Frontal lobe dysfunction in amyotrophic lateral sclerosis. A PET study. Brain1996; 119: 2105\u201320.","DOI":"10.1093\/brain\/119.6.2105"},{"key":"key\n\t\t\t\t20170624054850_AWH132C4","doi-asserted-by":"crossref","unstructured":"Abrahams S, Leigh PN, Harvey A, Vythelingum GN, Grise D, Goldstein LH. Verbal fluency and executive dysfunction in amyotrophic lateral sclerosis (ALS). Neuropsychologia2000; 38: 734\u201347.","DOI":"10.1016\/S0028-3932(99)00146-3"},{"key":"key\n\t\t\t\t20170624054850_AWH132C5","doi-asserted-by":"crossref","unstructured":"Al\u2010Sarraj S, Maekawa S, Kibble M, Everall I, Leigh PN. Ubiquitin\u2010only intraneuronal inclusion in the substantia nigra is a characteristic feature of motor neuron disease with dementia. Neuropathol Appl Neurobiol2002; 28: 120\u20138.","DOI":"10.1046\/j.1365-2990.2002.00384.x"},{"key":"key\n\t\t\t\t20170624054850_AWH132C6","doi-asserted-by":"crossref","unstructured":"Bak TH, Hodges JR. Cognition, language and behaviour in motor neurone disease: evidence of frontotemporal dysfunction. [Review]. Dement Geriatr Cogn Disord1999; 10 Suppl 1: 29\u201332.","DOI":"10.1159\/000051208"},{"key":"key\n\t\t\t\t20170624054850_AWH132C7","doi-asserted-by":"crossref","unstructured":"Baleydier C, Achache P, Froment JC. Neurofilament architecture of superior and mesial premotor cortex in the human brain. Neuroreport1997; 8: 1691\u20136.","DOI":"10.1097\/00001756-199705060-00026"},{"key":"key\n\t\t\t\t20170624054850_AWH132C8","doi-asserted-by":"crossref","unstructured":"Barr ML, Hamilton JD. A quantitative study of certain morphological changes in spinal motor neurons during axon reaction. J Comp Neurol1948; 89: 93\u2013121.","DOI":"10.1002\/cne.900890203"},{"key":"key\n\t\t\t\t20170624054850_AWH132C9","doi-asserted-by":"crossref","unstructured":"Benes FM, Lange N. Two\u2010dimensional versus three\u2010dimensional cell counting: a practical perspective. Trends Neurosci2001; 24: 11\u20137.","DOI":"10.1016\/S0166-2236(00)01660-X"},{"key":"key\n\t\t\t\t20170624054850_AWH132C10","doi-asserted-by":"crossref","unstructured":"Bergmann M. Motor neuron disease\/amyotrophic lateral sclerosis\u2013lessons from ubiquitin. Pathol Res Pract1993; 189: 902\u201312.","DOI":"10.1016\/S0344-0338(11)81102-7"},{"key":"key\n\t\t\t\t20170624054850_AWH132C11","unstructured":"Brodal P. Cerebral cortex. In: Brodal P. The central nervous system: structure and function. New York: Oxford University Press; 1992. p. 398\u2013424."},{"key":"key\n\t\t\t\t20170624054850_AWH132C12","doi-asserted-by":"crossref","unstructured":"Brownell B, Oppenheimer DR, Hughes JT. The central nervous system in motor neurone disease. J Neurol Neurosurg Psychiatry1970; 33: 338\u201357.","DOI":"10.1136\/jnnp.33.3.338"},{"key":"key\n\t\t\t\t20170624054850_AWH132C13","doi-asserted-by":"crossref","unstructured":"Cabello CR, Thune JJ, Pakkenberg H, Pakkenberg B. Ageing of substantia nigra in humans: cell loss may be compensated by hypertrophy. Neuropathol Appl Neurobiol2002; 28: 283\u201391.","DOI":"10.1046\/j.1365-2990.2002.00393.x"},{"key":"key\n\t\t\t\t20170624054850_AWH132C14","doi-asserted-by":"crossref","unstructured":"Campbell MJ, Morrison JH. Monoclonal antibody to neurofilament protein (SMI\u201032) labels a subpopulation of pyramidal neurons in the human and monkey neocortex. J Comp Neurol1989; 282: 191\u2013205.","DOI":"10.1002\/cne.902820204"},{"key":"key\n\t\t\t\t20170624054850_AWH132C15","doi-asserted-by":"crossref","unstructured":"Caramia MD, Palmieri MG, Desiato MT, Iani C, Scalise A, Telera S, et al. Pharmacologic reversal of cortical hyperexcitability in patients with ALS. Neurology2000; 54: 58\u201364.","DOI":"10.1212\/WNL.54.1.58"},{"key":"key\n\t\t\t\t20170624054850_AWH132C16","doi-asserted-by":"crossref","unstructured":"Carriedo SG, Yin HZ, Lamberta R, Weiss JH. In vitro kainate injury to large, SMI\u201032(+) spinal neurons is Ca2+ dependent. Neuroreport1995; 6: 945\u20138.","DOI":"10.1097\/00001756-199504190-00030"},{"key":"key\n\t\t\t\t20170624054850_AWH132C17","doi-asserted-by":"crossref","unstructured":"Carriedo SG, Yin HZ, Weiss JH. Motor neurons are selectively vulnerable to AMPA\/kainate receptor\u2010mediated injury in vitro. J Neurosci1996; 16: 4069\u201379.","DOI":"10.1523\/JNEUROSCI.16-13-04069.1996"},{"key":"key\n\t\t\t\t20170624054850_AWH132C18","doi-asserted-by":"crossref","unstructured":"Celio MR. Calbindin D\u201028k and parvalbumin in the rat nervous system. Neuroscience1990; 35: 375\u2013475.","DOI":"10.1016\/0306-4522(90)90091-H"},{"key":"key\n\t\t\t\t20170624054850_AWH132C19","doi-asserted-by":"crossref","unstructured":"Celio MR, Baier W, Scharer L, Gregersen HJ, de Viragh PA, Norman AW. Monoclonal antibodies directed against the calcium binding protein Calbindin D\u201028k. Cell Calcium1990; 11: 599\u2013602.","DOI":"10.1016\/0143-4160(90)90014-L"},{"key":"key\n\t\t\t\t20170624054850_AWH132C20","doi-asserted-by":"crossref","unstructured":"Chari G, Shaw PJ, Sahgal A. Nonverbal visual attention, but not recognition memory of learning, processes are impaired in motor neurone disease. Neuropsychologia1996; 34: 377\u201385.","DOI":"10.1016\/0028-3932(95)00122-0"},{"key":"key\n\t\t\t\t20170624054850_AWH132C21","doi-asserted-by":"crossref","unstructured":"Chou SM. Pathology of motor system disorder. In: Leigh PN, Swash M, editors. Motor neuron disease. London: Springer\u2010Verlag; 1995. p. 53\u201392.","DOI":"10.1007\/978-1-4471-1871-8_4"},{"key":"key\n\t\t\t\t20170624054850_AWH132C22","doi-asserted-by":"crossref","unstructured":"Cleveland DW, Rothstein JD. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. [Review]. Nat Rev Neurosci2001; 2: 806\u201319.","DOI":"10.1038\/35097565"},{"key":"key\n\t\t\t\t20170624054850_AWH132C23","doi-asserted-by":"crossref","unstructured":"Comoletti D, Muzio V, Capobianco A, Ravizza T, Mennini T. Nitric oxide produced by non\u2010motoneuron cells enhances rat embryonic motoneuron sensitivity to excitotoxins: comparison in mixed neuron\/glia or purified cultures. J Neurol Sci2001; 192: 61\u20139.","DOI":"10.1016\/S0022-510X(01)00607-4"},{"key":"key\n\t\t\t\t20170624054850_AWH132C24","doi-asserted-by":"crossref","unstructured":"Cotter D, Landau S, Beasley C, Stevenson R, Chana G, MacMillan L, et al. The density and spatial distribution of GABAergic neurons, labelled using calcium binding proteins, in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia. Biol Psychiatry2002; 51: 377\u201386.","DOI":"10.1016\/S0006-3223(01)01243-4"},{"key":"key\n\t\t\t\t20170624054850_AWH132C25","doi-asserted-by":"crossref","unstructured":"Cudkowicz M, Kowall NW. Degeneration of pyramidal projection neurons in Huntington\u2019s disease cortex. Ann Neurol1990; 27: 200\u20134.","DOI":"10.1002\/ana.410270217"},{"key":"key\n\t\t\t\t20170624054850_AWH132C26","doi-asserted-by":"crossref","unstructured":"David AS, Gillham RA. Neuropsychological study of motor neuron disease. Psychosomatics1986; 27: 441\u20135.","DOI":"10.1016\/S0033-3182(86)72673-X"},{"key":"key\n\t\t\t\t20170624054850_AWH132C27","doi-asserted-by":"crossref","unstructured":"Davison C. Amyotrophic lateral sclerosis: origin and extent of the upper motor neuron lesion. Arch Neurol Psychiatry1941; 46: 1039\u201356.","DOI":"10.1001\/archneurpsyc.1941.02280240094006"},{"key":"key\n\t\t\t\t20170624054850_AWH132C28","doi-asserted-by":"crossref","unstructured":"DeFelipe J. Types of neurons, synaptic connections and chemical characteristics of cells immunoreactive for calbindin\u2010D28K, parvalbumin and calretinin in the neocortex. [Review]. J Chem Neuroanat1997; 14: 1\u201319.","DOI":"10.1016\/S0891-0618(97)10013-8"},{"key":"key\n\t\t\t\t20170624054850_AWH132C29","doi-asserted-by":"crossref","unstructured":"Del R\u00edo MR, DeFelipe J. A study of SMI 32\u2010stained pyramidal cells, parvalbumin\u2010immunoreactive chandelier cells, and presumptive thalamocortical axons in the human temporal neocortex. J Comp Neurol1994; 342: 389\u2013408.","DOI":"10.1002\/cne.903420307"},{"key":"key\n\t\t\t\t20170624054850_AWH132C30","doi-asserted-by":"crossref","unstructured":"Demeulemeester H, Vandesande F, Orban GA, Brandon C, Vanderhaeghen JJ. Heterogeneity of GABAergic cells in cat visual cortex. J Neurosci1988; 8: 988\u20131000.","DOI":"10.1523\/JNEUROSCI.08-03-00988.1988"},{"key":"key\n\t\t\t\t20170624054850_AWH132C31","doi-asserted-by":"crossref","unstructured":"Eisen A. Clinical electrophysiology of the upper and lower motor neuron in amyotrophic lateral sclerosis. [Review]. Semin Neurol2001; 21: 141\u201354.","DOI":"10.1055\/s-2001-15261"},{"key":"key\n\t\t\t\t20170624054850_AWH132C32","doi-asserted-by":"crossref","unstructured":"Ellis CM, Suckling J, Amaro E Jr, Bullmore ET, Simmons A, Williams SC, et al. Volumetric analysis reveals corticospinal tract degeneration and extramotor involvement in ALS. Neurology2001; 57: 1571\u20138.","DOI":"10.1212\/WNL.57.9.1571"},{"key":"key\n\t\t\t\t20170624054850_AWH132C33","doi-asserted-by":"crossref","unstructured":"Ferrer I, Tunon T, Serrano MT, Casas R, Alcantara S, Zujar MJ, et al. Calbindin D\u201028k and parvalbumin immunoreactivity in the frontal cortex in patients with frontal lobe dementia of non\u2010Alzheimer type associated with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry1993; 56: 257\u201361.","DOI":"10.1136\/jnnp.56.3.257"},{"key":"key\n\t\t\t\t20170624054850_AWH132C34","doi-asserted-by":"crossref","unstructured":"Ferrer I, Olive M, Rivera R, Pou A, Narberhaus B, Ugarte A. Hereditary spastic paraparesis with dementia, amyotrophy and peripheral neuropathy. A neuropathological study. Neuropathol Appl Neurobiol1995; 21: 255\u201361.","DOI":"10.1111\/j.1365-2990.1995.tb01057.x"},{"key":"key\n\t\t\t\t20170624054850_AWH132C35","doi-asserted-by":"crossref","unstructured":"Gallassi R, Montagna P, Ciardulli C, Lorusso S, Mussuto V, Stracciari A. Cognitive impairment in motor neuron disease. Acta Neurol Scand1985; 71: 480\u20134.","DOI":"10.1111\/j.1600-0404.1985.tb03231.x"},{"key":"key\n\t\t\t\t20170624054850_AWH132C36","doi-asserted-by":"crossref","unstructured":"Ginsberg SD, Martin LJ, Rothstein JD. Regional deafferentation down\u2010regulates subtypes of glutamate transporter proteins. J Neurochem1995; 65: 2800\u20133.","DOI":"10.1046\/j.1471-4159.1995.65062800.x"},{"key":"key\n\t\t\t\t20170624054850_AWH132C37","doi-asserted-by":"crossref","unstructured":"Gredal O, Pakkenberg H, Karlsborg M, Pakkenberg B. Unchanged total number of neurons in motor cortex and neocortex in amyotrophic lateral sclerosis: a stereological study. J Neurosci Methods2000; 95: 171\u20136.","DOI":"10.1016\/S0165-0270(99)00175-2"},{"key":"key\n\t\t\t\t20170624054850_AWH132C38","doi-asserted-by":"crossref","unstructured":"Greene JR, Radenahmad N, Wilcock GK, Neal JW, Pearson RC. Accumulation of calbindin in cortical pyramidal cells with ageing; a putative protective mechanism which fails in Alzheimer\u2019s disease. Neuropathol Appl Neurobiol2001; 27: 339\u201342.","DOI":"10.1046\/j.0305-1846.2001.00351.x"},{"key":"key\n\t\t\t\t20170624054850_AWH132C39","doi-asserted-by":"crossref","unstructured":"Hammer RP Jr, Tomiyasu U, Scheibel AB. Degeneration of the human Betz cell due to amyotrophic lateral sclerosis. Exp Neurol1979; 63: 336\u201346.","DOI":"10.1016\/0014-4886(79)90129-8"},{"key":"key\n\t\t\t\t20170624054850_AWH132C40","doi-asserted-by":"crossref","unstructured":"Hedreen JC. Lost caps in histological counting methods. Anat Rec1998; 250: 366\u201372.","DOI":"10.1002\/(SICI)1097-0185(199803)250:3<366::AID-AR11>3.0.CO;2-M"},{"key":"key\n\t\t\t\t20170624054850_AWH132C41","doi-asserted-by":"crossref","unstructured":"Heizmann CW, Braun K. Changes in Ca(2+)\u2010binding proteins in human neurodegenerative disorders. [Review]. Trends Neurosci1992; 15: 259\u201364.","DOI":"10.1016\/0166-2236(92)90067-I"},{"key":"key\n\t\t\t\t20170624054850_AWH132C42","doi-asserted-by":"crossref","unstructured":"Hof PR, Cox K, Morrison JH. Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer\u2019s disease: I. Superior frontal and inferior temporal cortex. J Comp Neurol1990; 301: 44\u201354.","DOI":"10.1002\/cne.903010105"},{"key":"key\n\t\t\t\t20170624054850_AWH132C43","doi-asserted-by":"crossref","unstructured":"Hof PR, Nimchinsky EA, Buee\u2010Scherrer V, Buee L, Nasrallah J, Hottinger AF, et al. Amyotrophic lateral sclerosis\/parkinsonism\u2010dementia complex of Guam: quantitative neuropathology, immunohistochemical analysis of neuronal vulnerability, and comparison with related neurodegenerative disorders. Acta Neuropathol (Berl) 1994; 88: 397\u2013404.","DOI":"10.1007\/BF00389490"},{"key":"key\n\t\t\t\t20170624054850_AWH132C44","doi-asserted-by":"crossref","unstructured":"Hof PR, Ungerleider LG, Webster MJ, Gattass R, Adams MM, Sailstad CA, et al. Neurofilament protein is differentially distributed in subpopulations of corticocortical projection neurons in the macaque monkey visual pathways. J Comp Neurol1996; 376: 112\u201327.","DOI":"10.1002\/(SICI)1096-9861(19961202)376:1<112::AID-CNE7>3.0.CO;2-6"},{"key":"key\n\t\t\t\t20170624054850_AWH132C45","doi-asserted-by":"crossref","unstructured":"Hof PR, Duan H, Page TL, Einstein M, Wicinski B, He Y, et al. Age\u2010related changes in GluR2 and NMDAR1 glutamate receptor subunit protein immunoreactivity in corticocortically projecting neurons in macaque and patas monkeys. Brain Res2002; 928: 175\u201386.","DOI":"10.1016\/S0006-8993(01)03345-5"},{"key":"key\n\t\t\t\t20170624054850_AWH132C46","unstructured":"Hughes JT. Pathology of amyotrophic lateral sclerosis. Adv Neurol1982; 36: 61\u201374."},{"key":"key\n\t\t\t\t20170624054850_AWH132C47","doi-asserted-by":"crossref","unstructured":"Ince P, Stout N, Shaw P, Slade J, Hunziker W, Heizmann CW, Baimbridge KG. Parvalbumin and calbindin D\u201028k in the human motor system and in motor neuron disease. Neuropathol Appl Neurobiol1993; 19: 291\u20139.","DOI":"10.1111\/j.1365-2990.1993.tb00443.x"},{"key":"key\n\t\t\t\t20170624054850_AWH132C48","doi-asserted-by":"crossref","unstructured":"Ince PG, Shaw PJ, Slade JY, Jones C, Hudgson P. Familial amyotrophic lateral sclerosis with a mutation in exon 4 of the Cu\/Zn superoxide dismutase gene: pathological and immunocytochemical changes. [Review]. Acta Neuropathol (Berl) 1996; 92: 395\u2013403.","DOI":"10.1007\/s004010050535"},{"key":"key\n\t\t\t\t20170624054850_AWH132C49","doi-asserted-by":"crossref","unstructured":"Ince PG, Lowe J, Shaw PJ. Amyotrophic lateral sclerosis: current issues in classification, pathogenesis and molecular pathology. [Review]. Neuropathol Appl Neurobiol1998; 24: 104\u201317.","DOI":"10.1046\/j.1365-2990.1998.00108.x"},{"key":"key\n\t\t\t\t20170624054850_AWH132C50","doi-asserted-by":"crossref","unstructured":"Jackson M, Lennox G, Lowe J. Motor neurone disease\u2014inclusion dementia. Neurodegeneration1996; 5: 339\u2013350.","DOI":"10.1006\/neur.1996.0046"},{"key":"key\n\t\t\t\t20170624054850_AWH132C51","unstructured":"Kew JJM, Leigh PN. Dementia with motor neuron disease. In: Rossor M, editor. Unusual Dementias. Bailli\u00e8re\u2019s clinical neurology, Vol. 1, No. 3. London: Bailli\u00e8re Tindall; 1992. pp. 611\u201326."},{"key":"key\n\t\t\t\t20170624054850_AWH132C52","doi-asserted-by":"crossref","unstructured":"Kew JJ, Goldstein LH, Leigh PN, Abrahams S, Cosgrave N, Passingham RE, et al. The relationship between abnormalities of cognitive function and cerebral activation in amyotrophic lateral sclerosis. A neuropsychological and positron emission tomography study. Brain1993a; 116: 1399\u2013423.","DOI":"10.1093\/brain\/116.6.1399"},{"key":"key\n\t\t\t\t20170624054850_AWH132C53","doi-asserted-by":"crossref","unstructured":"Kew JJ, Leigh PN, Playford ED, Passingham RE, Goldstein LH, Frackowiak RS, Brooks DJ. Cortical function in amyotrophic lateral sclerosis. A positron emission tomography study. Brain1993b; 116: 655\u201380.","DOI":"10.1093\/brain\/116.3.655"},{"key":"key\n\t\t\t\t20170624054850_AWH132C54","doi-asserted-by":"crossref","unstructured":"Kiernan JA, Hudson AJ. Changes in sizes of cortical and lower motor neurons in amyotrophic lateral sclerosis. Brain1991; 114: 843\u201353.","DOI":"10.1093\/brain\/114.2.843"},{"key":"key\n\t\t\t\t20170624054850_AWH132C55","doi-asserted-by":"crossref","unstructured":"Kiernan JA, Hudson AJ. Changes in shapes of surviving motor neurons in amyotrophic lateral sclerosis. Brain1993; 116: 203\u201315.","DOI":"10.1093\/brain\/116.1.203"},{"key":"key\n\t\t\t\t20170624054850_AWH132C56","doi-asserted-by":"crossref","unstructured":"Kondo H, Tanaka K, Hashikawa T, Jones EG. Neurochemical gradients along monkey sensory cortical pathways: calbindin\u2010immunoreactive pyramidal neurons in layers II and III. Eur J Neurosci1999; 11: 4197\u2013203.","DOI":"10.1046\/j.1460-9568.1999.00844.x"},{"key":"key\n\t\t\t\t20170624054850_AWH132C57","doi-asserted-by":"crossref","unstructured":"Lassek AM. The human pyramidal tract: II. A numerical investigation of the Betz cells of the motor area. Arch Neurol Psychiatry1940; 44: 718\u201324.","DOI":"10.1001\/archneurpsyc.1940.02280100020002"},{"key":"key\n\t\t\t\t20170624054850_AWH132C58","doi-asserted-by":"crossref","unstructured":"Leigh PN, Meldrum BS. Excitotoxicity in ALS. [Review]. Neurology1996; 47 (6 Suppl 4): S221\u20137.","DOI":"10.1212\/WNL.47.6_Suppl_4.221S"},{"key":"key\n\t\t\t\t20170624054850_AWH132C59","doi-asserted-by":"crossref","unstructured":"Leigh PN, Simmons A, Williams S, Williams V, Turner M, Brooks D. Imaging: MRS\/MRI\/PET\/SPECT: summary. Amyotroph Lateral Scler Other Motor Neuron Disord2002; 3 Suppl 1: S75\u201380.","DOI":"10.1080\/146608202320374372"},{"key":"key\n\t\t\t\t20170624054850_AWH132C60","doi-asserted-by":"crossref","unstructured":"Lloyd CM, Richardson MP, Brooks DJ, Al\u2010Chalabi A, Leigh PN. Extramotor involvement in ALS: PET studies with the GABA(A) ligand [(11)C]flumazenil. Brain2000; 123: 2289\u201396.","DOI":"10.1093\/brain\/123.11.2289"},{"key":"key\n\t\t\t\t20170624054850_AWH132C61","doi-asserted-by":"crossref","unstructured":"Lomen\u2010Hoerth C, Murphy J, Langmore S, Kramer JH, Olney RK, Miller B. Are amyotrophic lateral sclerosis patients cognitively normal? Neurology2003; 60: 1094\u20137.","DOI":"10.1212\/01.WNL.0000055861.95202.8D"},{"key":"key\n\t\t\t\t20170624054850_AWH132C62","doi-asserted-by":"crossref","unstructured":"Ludolph AC, Langen KJ, Regard M, Herzog H, Kemper B, Kuwert T, et al. Frontal lobe function in amyotrophic lateral sclerosis: a neuropsychologic and positron emission tomography study. Acta Neurol Scand1992; 85: 81\u20139.","DOI":"10.1111\/j.1600-0404.1992.tb04003.x"},{"key":"key\n\t\t\t\t20170624054850_AWH132C63","doi-asserted-by":"crossref","unstructured":"Macdonald V, Halliday GM, Trent RJ, McCusker EA. Significant loss of pyramidal neurons in the angular gyrus of patients with Huntington\u2019s disease. Neuropathol Appl Neurobiol1997; 23: 492\u20135.","DOI":"10.1111\/j.1365-2990.1997.tb01326.x"},{"key":"key\n\t\t\t\t20170624054850_AWH132C64","doi-asserted-by":"crossref","unstructured":"Maragakis NJ, Rothstein JD. Glutamate transporters in neurologic disease. [Review]. Arch Neurol2001; 58: 365\u201370.","DOI":"10.1001\/archneur.58.3.365"},{"key":"key\n\t\t\t\t20170624054850_AWH132C65","doi-asserted-by":"crossref","unstructured":"Massman PJ, Sims J, Cooke N, Haverkamp LJ, Appel V, Appel SH. Prevalence and correlates of neuropsychological deficits in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry1996; 61: 450\u20135.","DOI":"10.1136\/jnnp.61.5.450"},{"key":"key\n\t\t\t\t20170624054850_AWH132C66","doi-asserted-by":"crossref","unstructured":"Mesulam M, Geula C. Differential distribution of a neurofilament protein epitope in acetylcholinesterase\u2010rich neurons of human cerebral neocortex. Brain Res1991; 544: 169\u201373.","DOI":"10.1016\/0006-8993(91)90901-7"},{"key":"key\n\t\t\t\t20170624054850_AWH132C67","doi-asserted-by":"crossref","unstructured":"Morrison JH, Lewis DA, Campbell MJ, Huntley GW, Benson DL, Bouras C. A monoclonal antibody to non\u2010phosphorylated neurofilament protein marks the vulnerable cortical neurons in Alzheimer\u2019s disease. Brain Res1987; 416: 331\u20136.","DOI":"10.1016\/0006-8993(87)90914-0"},{"key":"key\n\t\t\t\t20170624054850_AWH132C68","doi-asserted-by":"crossref","unstructured":"Munoz DG, Greene C, Perl DP, Selkoe DJ. Accumulation of phosphorylated neurofilaments in anterior horn motoneurons of amyotrophic lateral sclerosis patients. J Neuropathol Exp Neurol1988; 47: 9\u201318.","DOI":"10.1097\/00005072-198801000-00002"},{"key":"key\n\t\t\t\t20170624054850_AWH132C69","doi-asserted-by":"crossref","unstructured":"Murakami T. Motor neuron disease: quantitative morphological and microdensitophotometric studies of neurons of anterior horn and ventral root of cervical spinal cord with special reference to the pathogenesis. J Neurol Sci1990; 99: 101\u201315.","DOI":"10.1016\/0022-510X(90)90204-Z"},{"key":"key\n\t\t\t\t20170624054850_AWH132C70","doi-asserted-by":"crossref","unstructured":"Murayama S, Bouldin TW, Suzuki K. Immunocytochemical and ultrastructural studies of upper motor neurons in amyotrophic lateral sclerosis. Acta Neuropathol (Berl) 1992; 83: 518\u201324.","DOI":"10.1007\/BF00310029"},{"key":"key\n\t\t\t\t20170624054850_AWH132C71","doi-asserted-by":"crossref","unstructured":"Nakano I. Frontotemporal dementia with motor neuron disease (amyotrophic lateral sclerosis with dementia). [Review]. Neuropathology2000; 20: 68\u201375.","DOI":"10.1046\/j.1440-1789.2000.00272.x"},{"key":"key\n\t\t\t\t20170624054850_AWH132C73","unstructured":"Nihei K, McKee AC, Kowall NW. Degeneration of non pyramidal local circuit neurons in the motor cortex of amyotrophic lateral sclerosis patients [abstract]. J Neuropathol Exp Neurol1992; 51: 322."},{"key":"key\n\t\t\t\t20170624054850_AWH132C74","doi-asserted-by":"crossref","unstructured":"Nihei K, McKee AC, Kowall NW. Patterns of neuronal degeneration in the motor cortex of amyotrophic lateral sclerosis patients. Acta Neuropathol (Berl) 1993; 86: 55\u201364","DOI":"10.1007\/BF00454899"},{"key":"key\n\t\t\t\t20170624054850_AWH132C75","doi-asserted-by":"crossref","unstructured":"Nyberg\u2010Hansen R, Rinvik E. Some comments on the pyramidal tract, with special reference to its individual variations in man. Acta Neurol Scand1963; 39: 1\u201330.","DOI":"10.1111\/j.1600-0404.1963.tb05384.x"},{"key":"key\n\t\t\t\t20170624054850_AWH132C76","doi-asserted-by":"crossref","unstructured":"Okamoto K, Murakami N, Kusaka H, Yoshida M, Hashizume Y, Nakazato Y, et al. Ubiquitin\u2010positive intraneuronal inclusions in the extramotor cortices of presenile dementia patients with motor neuron disease. J Neurol1992; 239: 426\u201330.","DOI":"10.1007\/BF00856806"},{"key":"key\n\t\t\t\t20170624054850_AWH132C77","doi-asserted-by":"crossref","unstructured":"Petrides M, Pandya DN. Dorsolateral prefrontal cortex: comparative cytoarchitectonic analysis in the human and the macaque brain and corticocortical connection patterns. Eur J Neurosci1999; 11: 1011\u201336","DOI":"10.1046\/j.1460-9568.1999.00518.x"},{"key":"key\n\t\t\t\t20170624054850_AWH132C78","unstructured":"Rothstein JD. Excitotoxic mechanisms in the pathogenesis of amyotrophic lateral sclerosis. [Review]. Adv Neurol1995; 68: 7\u201320."},{"key":"key\n\t\t\t\t20170624054850_AWH132C79","doi-asserted-by":"crossref","unstructured":"Rothstein JD. Excitotoxicity hypothesis. [Review]. Neurology1996; 47 (4 Suppl 2): S19\u201325.","DOI":"10.1212\/WNL.47.4_Suppl_2.19S"},{"key":"key\n\t\t\t\t20170624054850_AWH132C80","doi-asserted-by":"crossref","unstructured":"Saroff D, Delfs J, Kuznetsov D, Geula C. Selective vulnerability of spinal cord motor neurons to non\u2010NMDA toxicity. Neuroreport2000; 11: 1117\u201321.","DOI":"10.1097\/00001756-200004070-00041"},{"key":"key\n\t\t\t\t20170624054850_AWH132C81","doi-asserted-by":"crossref","unstructured":"Sasaki S, Maruyama S. Immunocytochemical and ultrastructural studies of the motor cortex in amyotrophic lateral sclerosis. Acta Neuropathol (Berl) 1994; 87: 578\u201385.","DOI":"10.1007\/BF00293318"},{"key":"key\n\t\t\t\t20170624054850_AWH132C82","doi-asserted-by":"crossref","unstructured":"Shaw PJ. Excitotoxicity and motor neurone disease: a review of the evidence. [Review]. J Neurol Sci1994; 124 Suppl: 6\u201313.","DOI":"10.1016\/0022-510X(94)90170-8"},{"key":"key\n\t\t\t\t20170624054850_AWH132C83","doi-asserted-by":"crossref","unstructured":"Shaw PJ, Ince PG. Glutamate, excitotoxicity and amyotrophic lateral sclerosis. [Review]. J Neurol1997; 244 (Suppl 2): S3\u201014.","DOI":"10.1007\/BF03160574"},{"key":"key\n\t\t\t\t20170624054850_AWH132C84","doi-asserted-by":"crossref","unstructured":"Sommer M, Tergau F, Wischer S, Reimers CD, Beuche W, Paulus W. Riluzole does not have an acute effect on motor thresholds and the intracortical excitability in amyotrophic lateral sclerosis. J Neurol1999; 246 Suppl 3: III22\u20136.","DOI":"10.1007\/BF03161086"},{"key":"key\n\t\t\t\t20170624054850_AWH132C85","doi-asserted-by":"crossref","unstructured":"Stefan K, Kunesch E, Benecke R, Classen J. Effects of riluzole on cortical excitability in patients with amyotrophic lateral sclerosis. Ann Neurol2001; 49: 536\u20139.","DOI":"10.1002\/ana.107"},{"key":"key\n\t\t\t\t20170624054850_AWH132C86","doi-asserted-by":"crossref","unstructured":"Sternberger LA. Immunocytochemistry. 3rd ed. New York: Wiley; 1985.","DOI":"10.1007\/978-1-4613-2615-1_2"},{"key":"key\n\t\t\t\t20170624054850_AWH132C87","doi-asserted-by":"crossref","unstructured":"Strong MJ, Grace GM, Orange JB, Leeper HA, Menon RS, Aere C. A prospective study of cognitive impairment in ALS. Neurology1999; 53: 1665\u201370.","DOI":"10.1212\/WNL.53.8.1665"},{"key":"key\n\t\t\t\t20170624054850_AWH132C88","doi-asserted-by":"crossref","unstructured":"Troost D, Sillevis Smitt PA, de Jong JM, Swaab DF. Neurofilament and glial alterations in the cerebral cortex in amyotrophic lateral sclerosis. Acta Neuropathol (Berl) 1992; 84: 664\u201373.","DOI":"10.1007\/BF00227744"},{"key":"key\n\t\t\t\t20170624054850_AWH132C89","doi-asserted-by":"crossref","unstructured":"Tsang YM, Chiong F, Kuznetsov D, Kasarskis E, Geula C. Motor neurons are rich in non\u2010phosphorylated neurofilaments: cross\u2010species comparison and alterations in ALS. Brain Res2000; 861: 45\u201358.","DOI":"10.1016\/S0006-8993(00)01954-5"},{"key":"key\n\t\t\t\t20170624054850_AWH132C90","doi-asserted-by":"crossref","unstructured":"Udaka F, Kameyama M, Tomonaga M. Degeneration of Betz cells in motor neuron disease. A Golgi study. Acta Neuropathol (Berl) 1986; 70: 289\u201395.","DOI":"10.1007\/BF00686086"},{"key":"key\n\t\t\t\t20170624054850_AWH132C91","doi-asserted-by":"crossref","unstructured":"Urushitani M, Shimohama S, Kihara T, Sawada H, Akaike A, Ibi M, et al. Mechanism of selective motor neuronal death after exposure of spinal cord to glutamate: involvement of glutamate\u2010induced nitric oxide in motor neuron toxicity and nonmotor neuron protection. Ann Neurol1998; 44: 796\u2013807.","DOI":"10.1002\/ana.410440514"},{"key":"key\n\t\t\t\t20170624054850_AWH132C92","doi-asserted-by":"crossref","unstructured":"Vandenberghe W, Robberecht W, Brorson JR. AMPA receptor calcium permeability, GluR2 expression, and selective motoneuron vulnerability. J Neurosci2000a; 20: 123\u201332.","DOI":"10.1523\/JNEUROSCI.20-01-00123.2000"},{"key":"key\n\t\t\t\t20170624054850_AWH132C93","doi-asserted-by":"crossref","unstructured":"Vandenberghe W, Ihle EC, Patneau DK, Robberecht W, Brorson JR. AMPA receptor current density, not desensitization, predicts selective motoneuron vulnerability. J Neurosci2000b; 20: 7158\u201366.","DOI":"10.1523\/JNEUROSCI.20-19-07158.2000"},{"key":"key\n\t\t\t\t20170624054850_AWH132C94","doi-asserted-by":"crossref","unstructured":"Vandenberghe W, Bindokas VP, Miller RJ, Robberecht W, Brorson JR. Subcellular localization of calcium\u2010permeable AMPA receptors in spinal motoneurons. Eur J Neurosci2001; 14: 305\u201314.","DOI":"10.1046\/j.0953-816x.2001.01648.x"},{"key":"key\n\t\t\t\t20170624054850_AWH132C95","doi-asserted-by":"crossref","unstructured":"Vogt BA, Nimchinsky EA, Vogt LJ, Hof PR. Human cingulate cortex: surface features, flat maps, and cytoarchitecture. J Comp Neurol1995; 359: 490\u2013506.","DOI":"10.1002\/cne.903590310"},{"key":"key\n\t\t\t\t20170624054850_AWH132C96","doi-asserted-by":"crossref","unstructured":"Wightman G, Anderson VE, Martin J, Swash M, Anderton BH, Neary D, et al. Hippocampal and neocortical ubiquitin\u2010immunoreactive inclusions in amyotrophic lateral sclerosis with dementia. Neurosci Lett1992; 139: 269\u201374.","DOI":"10.1016\/0304-3940(92)90569-S"},{"key":"key\n\t\t\t\t20170624054850_AWH132C501","doi-asserted-by":"crossref","unstructured":"Young AB, Bromberg MB, Penney JB Jr. Decreased glutamate uptake in subcortical areas deafferented by sensorimotor cortical ablation in the cat. J Neurosci1981; 1: 241\u20139.","DOI":"10.1523\/JNEUROSCI.01-03-00241.1981"},{"key":"key\n\t\t\t\t20170624054850_AWH132C97","doi-asserted-by":"crossref","unstructured":"Zanette G, Tamburin S, Manganotti P, Refatti N, Forgione A, Rizzuto N. Different mechanisms contribute to motor cortex hyperexcitability in amyotrophic lateral sclerosis. Clin Neurophysiol2002a; 113: 1688\u201397.","DOI":"10.1016\/S1388-2457(02)00288-2"},{"key":"key\n\t\t\t\t20170624054850_AWH132C98","doi-asserted-by":"crossref","unstructured":"Zanette G, Tamburin S, Manganotti P, Refatti N, Forgione A, Rizzuto N. Changes in motor cortex inhibition over time in patients with amyotrophic lateral sclerosis. J Neurol2002b; 249: 1723\u20138.","DOI":"10.1007\/s00415-002-0926-7"},{"key":"key\n\t\t\t\t20170624054850_AWH132C99","doi-asserted-by":"crossref","unstructured":"Zeman S, Lloyd C, Meldrum B, Leigh PN. Excitatory amino acids, free radicals and the pathogenesis of motor neuron disease. [Review]. Neuropathol Appl Neurobiol1994; 20: 219\u201331.","DOI":"10.1111\/j.1365-2990.1994.tb00963.x"},{"key":"key\n\t\t\t\t20170624054850_AWH132C100","doi-asserted-by":"crossref","unstructured":"Ziemann U, Winter M, Reimers CD, Reimers K, Tergau F, Paulus W. Impaired motor cortex inhibition in patients with amyotrophic lateral sclerosis. Evidence from paired transcranial magnetic stimulation. Neurology1997; 49: 1292\u20138.","DOI":"10.1212\/WNL.49.5.1292"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/127\/6\/1237\/17869663\/awh132.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T03:32:41Z","timestamp":1585798361000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article-lookup\/doi\/10.1093\/brain\/awh132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":100,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2004,6]]},"published-print":{"date-parts":[[2004,6]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awh132","relation":{},"ISSN":["1460-2156","0006-8950"],"issn-type":[{"value":"1460-2156","type":"electronic"},{"value":"0006-8950","type":"print"}],"subject":[],"published":{"date-parts":[[2004,6]]}}}